ULTRAGENYX PHARMACEUTICAL INC (RARE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RARE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RARE | Board member and advisor to various life science companies; Board member and adviser to various life science companies | 69 | ["Board member and advisor to life science companies", "Executive Vice President at Juno Therapeutics, Inc.", "Strategic advisor to the Chief Medical Officer of Celgene Corporation", "Transition Advisor to the Clinical Development team at BMS", "Positions of increasing responsibility at Genentech/Roche", "Senior Vice President, Global Head of Clinical Operations and Industry Collaboration at Genentech/Roche", "B.S. and M.S. in Statistics from the University of the Philippines", "M.A. and Ph.D. in Statistics from the Wharton Doctoral Program at the University of Pennsylvania"] | ["Research and Development Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Sanders is a board member and advisor to life science companies. Dr. Sanders currently serves as a member of the board of directors of BeOne Medicines and Legend Biotech Corporation, each a publicly traded biotechnology company. She most recently served as Executive Vice President at Juno Therapeutics, Inc., a biopharmaceutical company, from 2017 to 2018 and strategic advisor to the Chief Medical Officer of Celgene Corporation, a biopharmaceutical company, from 2018 to 2019 following Juno s acquisition by Celgene. Following the acquisition of Celgene by Bristol Myers Squibb, Dr. Sanders served as Transition Advisor to the Clinical Development team at BMS from 2019 to 2020. Prior to her role at BMS, she held positions of increasing responsibility at Genentech/Roche, a biotechnology company, from 1994 to 2017, including serving as Senior Vice President, Global Head of Clinical Operations and Industry Collaboration, from 2012 to 2017. Dr. Sanders holds a B.S. and M.S. in Statistics, magna cum laude, from the University of the Philippines. She also holds an M.A. and Ph.D. in Statistics from the Wharton Doctoral Program at the University of Pennsylvania.